Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.
Temafloxacin, a new fluoroquinolone, was compared with amoxicillin in the treatment of adult hospitalized patients with community-acquired pneumonia. In this double-blind, multicenter study, patients were randomly assigned to treatment with temafloxacin at 600 mg twice daily (n = 125) or amoxicillin...
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1992
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1323954/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.833 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|